{
    "code": "02019539",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019539",
    "time": "2020-02-25 12:12:55",
    "許可證字號": "衛署藥輸字第019539號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/08\/16",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "96\/10\/13",
    "發證日期": "81\/10\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201953900",
    "中文品名": "協良行錠１公絲",
    "英文品名": "CELANCE TABLETS 1000 MICROGRAMS",
    "適應症": "輔助ＬＥＶＯＤＯＰＡ／ＣＡＲＢＩＤＯＰＡ以控制巴金森氏病。",
    "劑型": "110錠劑",
    "包裝": "1000錠以下鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "88\/10\/13",
    "主成分略述": "PERGOLIDE MESYLATE ( EQ. PERGOLIDE MESILATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1411301100  臺灣禮來股份有限公司",
    "申請商地址": "台北巿復興北路３６５號１１樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0073000  ELI. LILLY &amp; CO.",
            "製造廠廠址": "INDIANAPOLIS INDIANA 46285",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600001300",
            "成分名稱": "PERGOLIDE MESYLATE ( EQ. PERGOLIDE MESILATE)",
            "含量描述": "(1.31MG)",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020195390007.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02019539&Seq=007&Type=9"
        }
    ]
}